Show me jobs with…
Near this location
For International Job Search Please   Click Here
Company Profile
[ Jobs Posted ]   [ News ]
Ipsen

ABOUT IPSEN
Headquartered in Paris, Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding $1 billion in 2011.

Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Our development strategy is supported by four franchises: (1) neurology / Dysport®, (2) endocrinology / Somatuline®, (3) uro-oncology / Decapeptyl® and (4) hemophilia. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patient driven platforms, peptides and toxins.

In 2011, R&D expenditure totaled more than $300 million, above 21% of Group sales. The Group has total worldwide staff of close to 4,500 employees.

IPSEN IN MASSACHUSETTS
In Milford, Massachusetts, Ipsen Biomeasure Inc is home to 160 Ipsen employees, the Company is currently making a $45 million capital investment in its Milford research and development (R&D) and technical operations facility, notably bioproduction. The facility serves as a center for Ipsen US-based peptide and toxin R&D platforms, as well as a CGMP manufacturing facility focused on production of recombinant proteins for the treatment of hemophilia.

Milford’s renovated facility will house R&D and Process Sciences laboratories that support Ipsen strategic R&D objectives.
[ Go Back ]

Company HR Reps

Susan @ Ipsen

   


Image not available